Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lenvatinib
Related studies linked through entity extraction aliases.
Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)
- Status
- RECRUITING
- Phase
- PHASE2
Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC
- Status
- RECRUITING
- Phase
- PHASE2
Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)
- Status
- RECRUITING
- Phase
- PHASE2
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
- Status
- RECRUITING
- Phase
- N/A
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）
- Status
- RECRUITING
- Phase
- PHASE2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoantigen Derived DCs as Cancer Treatment
- Status
- RECRUITING
- Phase
- PHASE1
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A